BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
April 30, 2003
View Archived Issues
Diatos Licenses European Rights To Cancer Drug From Medarex
PARIS - Diatos SA and Medarex Inc. signed a licensing agreement giving Diatos exclusive European rights to develop and commercialize a potential new cancer treatment. (BioWorld International)
Read More
Biotech Groups In Norway Unite, Plan To Catch Up With Neighbors
Read More
Genetic Study Of Clotting Enzyme Points To 'Fantastic' Drug Target
Read More
Curnock Cook Investing Again After Forming New €150M Fund
No Abstract
Read More
PPL Gives Up Plans On Plant To Manufacture AAT Product
Read More
French Companies, Agency Unite For Effort In America
Read More
Alizyme Eyes Phase III, Alliance Following Renzapride Results
Read More
GenoWay Raises EUR3.3M To Fund Work On Animal, In Vitro Models
Read More
Merck Stops Development Of Celltech PDE-4 Inhibitor
Read More
UK Industry Gathers To Celebrate 50th Anniversary Of DNA Finding
Read More
Other News To Note
Read More